Menu
Warning! You won't be able to use the quotation basket until you enable cookies in your Web browser.
Warning! Your Web browser is no longer supported. Please upgrade to a modern browser.

Aperio VERSA - Visikol's Highly Multiplexed Immunohistochemistry Approach to Drug Discovery

Overview

Visikol is a biotechnology company focused on advanced imaging, digital pathology, and 3D cell culture assays that has developed a unique imaging platform that allows for 10+ plex immunofluorescent slide imaging. Through this presentation, Visikol will provide a background on various multiplex tissue imaging approaches and will describe how they can be used to answer complex research questions such as surveying the immune cell population within a tumor microenvironment, or evaluating therapeutics for infectious diseases. Specifically, Visikol will discuss how its proprietry multiplex approach has been leveraged through a partnership with Hackensack Meridian Health (HMH) to evaluate tuberculosis treatments. This work is funded by the Bill & Melinda Gates Foundation using Visikol’s multiplex approach combined with several imaging modalities to evaluate treatments using a multi-modal imaging approach.

Learning Objectives

  • Develop an understanding of multiplex slide labeling and imaging techniques.
  • Demonstrate a working knowledge of the multiple types of multiplex tools available for whole slide imaging.
  • Identify the unique types of research questions that can be addressed through multiplex imaging.

 

DON'T MISS OUT! SUBSCRIBE TO RESEARCH LINK TODAY TO GET QUATERLY UPDATES ON OUR LATEST LIFE SCIENCE ENDEAVOURS

Related Products

Aperio VERSA
Brightfield, Fluorescence & FISH Digital Pathology Scanner

For research use only. Not for use in diagnostic procedures.

Leica Biosystems content is subject to the Leica Biosystems website terms of use, available at: Legal Notice. The content, including webinars, training presentations and related materials is intended to provide general information regarding particular subjects of interest to health care professionals and is not intended to be, and should not be construed as, medical, regulatory or legal advice. The views and opinions expressed in any third-party content reflect the personal views and opinions of the speaker(s)/author(s) and do not necessarily represent or reflect the views or opinions of Leica Biosystems, its employees or agents. Any links contained in the content which provides access to third party resources or content is provided for convenience only.

For the use of any product, the applicable product documentation, including information guides, inserts and operation manuals should be consulted. Leica Biosystems and the editors hereby disclaim any liability arising directly or indirectly from the use of the content, including from any drugs, devices, techniques or procedures described in the content.

Copyright © 2021 Leica Biosystems division of Leica Microsystems, Inc. and its Leica Biosystems affiliates. All rights reserved. LEICA and the Leica Logo are registered trademarks of Leica Microsystems IR GmbH.